119th Congress · introduced in the House · Sep 21, 2026
Companion Animal Protection Against Cruel Testing Act
Official title from Congress.gov
Latest action (Sep 21, 2026): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Science, Technology, Communications
Congressional Research Service summary, version: Introduced in House (Sep 21, 2026)
Companion Animal Protection Against Cruel Testing Act
This bill prohibits the use of funds made available to covered federal agencies for any biomedical research activity involving a live dog or cat. Covered agencies are agencies or offices within the Department of Health and Human Services (HHS) that award, administer, or expend federal funds for biomedical research.
This prohibition also applies to activities that materially facilitate biomedical research involving a live dog or cat (e.g., salaries, facility maintenance, and administrative support primarily related to such research). It does not apply to transportation and rehousing of animals previously used in biomedical research or observational activities that do not involve alteration of an animal’s normal environment or medical care.
The prohibition applies to federal funds obligated or expended beginning 180 days after the bill is enacted. HHS may waive the prohibition in limited circumstances if necessary to respond to a specified emergency.
Recipients of funding from covered agencies must make reasonable efforts to transfer dogs and cats no longer needed for research to rescue organizations or other appropriate entities. Further, recipients may only euthanize an animal if a veterinarian has determined euthanasia is necessary for animal welfare or public safety.
If HHS determines that a recipient has violated a provision of the bill, it may withhold further funding to the recipient, recover funds expended in violation, and impose other administrative remedies.
Show the full summary (1 more paragraphs)Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
3 citations.
WHITE COAT WASTE PROJECT INC · lobbying firm or registrant: WHITE COAT WASTE PROJECT INC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Animals
$10,000
Spent on own lobbying
…at testing H.R.4512 - TRANS MICE Act- cuts funding for transgender animal experiments S.4172 - AFTER Act of 2026- retirement policy for animals in federal labs H.R.10522 - Companion Animal Protection Against Cruel Testing (COMPACT) Act- cuts funding for dog and cat labs, retires animals H.R.10523 - PUPPS Act- restricts breeding…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MARSHALL BIORESOURCES · lobbying firm or registrant: CHAMBER HILL STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
S. 5048/HR 7248, the FDA Modernization Act; issues related to pre-clinical research; HR 10522, the Companion Animal Protection Against Cruel Testing Act; HR 10532, the Beagle Liberation Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE · lobbying firm or registrant: PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 7, 2026 · issue area: Health Issues
$33,123
Spent on own lobbying
…Improvements to Animal Welfare Act TSCA reauthorization H.R.1085 / S. 1802 - CARGO Act of 2025 (support) PRIMATE Act H.R. 8471 Humane Cosmetics Act H.R. 1657. H.R.10522 - Companion Animal Protection Against Cruel Testing (COMPACT) Act - Support
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing